Bisa ga sanarwar PR Newswire da aka buga a ranar 17 ga Mayu, 2024 da misalin karfe 1:42 na safe, kamfanin WuXi Biologics ya taya kamfanin CANbridge Pharmaceuticals murnar samun amincewar maganin Velaglucerase-beta mai suna Gaurunning daga hukumar NMPA ta kasar China. An amince da wannan magani ne don magance cutar Gaucher. A takaice dai, an samu wani sabon magani don cutar Gaucher a China, kuma WuXi Biologics na murnar wannan nasara tare da kamfanin CANbridge Pharmaceuticals.
AI ta bayar da labari.
An yi amfani da tambayar mai zuwa don samar da amsa daga Google Gemini:
A 2025-05-17 01:42, ‘WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA’ an rubuta bisa ga PR Newswire. Da fatan za a rubuta cikakken bayani mai saukin fahimta. Da fatan za a amsa a cikin Hausa.
1202